Betamethason Sodium Phosphate

ApprovedSmall molecule

Betamethason Sodium Phosphate is one of 35 small molecule programs targeting Plantar Fasciitis. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Plantar FasciitisActive, not recruiting

ProstatitisActive, not recruiting

Plantar FasciitisPhase 1

Active, not recruiting

ProstatitisPhase 1

Active, not recruiting

Competition

Competitive Landscape

39 competitors in Plantar Fasciitis

#DrugCompanyPhaseTrials

Medrol

Pfizer

Approved

1 2

Plasma

CSL Behring

Approved

1 3

Marcaine

IInnocoll

Approved

—4

Xeomin

MMerz Therapeutics GmbH

Approved

1 5

Botox

RRevance Therapeutics, Inc.

Phase 3

1 6

Betamethason Sodium Phosphate

UUniversidad Autonoma de Nuevo Leon

Approved

1 7

Decadron

AAspen Global Incorporated

Phase 2

2 8

Methylprednisolon

SSisli Hamidiye Etfal Training and Research Hospital

Approved

1 9

Xiaflex

GGrupo Espanol de Tumores Neuroendocrinos

Phase 2

1 10

Botox

VVitae Pharmaceuticals Inc., an Allergan affiliate

Phase 2

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Stress1 trial

Stress and Fetal Brain Development

Recruiting·UUniversity Hospital Tuebingen··NCT03831126·24 enrolled

Prostatitis1 trial

Chronic Non Bacterial Prostatitis: a Trial of TRUS Guided Injection of Betamethason

Unknown status·—·Phase 1·NCT04210739·20 enrolled

RCT1 trial

Effects of ACS in Twin With LPB: Study Protocol for a RCT

Completed·SSeoul National University Hospital·Phase 2/3·NCT03547791·848 enrolled

Dexamethasone1 trial

Effect of Pre-delivery Dexamethasone in Comparison With Betamethasone on Fetal Heart Trace

Recruiting·RRawalpindi Medical College·Phase 4·NCT07078786·110 enrolled

Vomiting1 trial

Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy

Recruiting·UUmeå University·Phase 4·NCT03783182·100 enrolled

1 more indication

Plantar Fasciitis1 trial

Therapeutic Effect of Botulinum Toxin A for the Treatment of Plantar Fasciitis.

Completed·UUniversidad Autonoma de Nuevo Leon·Phase 1·NCT03054610·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Betamethason Sodium Phosphate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Betamethason Sodium Phosphate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Betamethason Sodium Phosphate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Universidad Autonoma de Nuevo Leon company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversidad Autonoma de Nuevo Leon

Betamethason Sodium Phosphate

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Stress1 trial

Prostatitis1 trial

RCT1 trial

Dexamethasone1 trial

Vomiting1 trial

Plantar Fasciitis1 trial

References

Drug Info

Quick Facts

Related News